Oxidative damage is a major contributing factor to carcinogenesis and obstructive disorders in lungs. Current evidence suggests that the inflammatory processes yield to oxidative mechanisms, which underlie COPD, lung cancer, and obstructive sleep apnea syndrome (OSAS). This study aimed to evaluate the oxidative damage in these diseases by evaluating the oxidative and antioxidant biomarkers.
METHODS:
Malondialdehyde, 8-oxo-7,8-dihydro-2′-deoxyguanosine, and coenzyme Q10 levels were evaluated in the blood samples of subjects with COPD, lung cancer, and OSAS by high-pressure liquid chromatography.
RESULTS:
A total of 111 participants (35 females, 76 males) with OSAS (n = 29), COPD (n = 26), and lung cancer (n = 28) and healthy controls (n = 28) were included in the study. The malondialdehyde and coenzyme Q10 levels were significantly higher in all 3 diseases when compared with controls (P < .01), whereas 8-oxo-7,8-dihydro-2′-deoxyguanosine levels were only significantly higher than in healthy controls in subjects with lung cancer (P = .005). The highest levels of malondialdehyde and coenzyme Q10 were determined in subjects with OSAS and lung cancer, respectively. The highest 8-oxo-7,8-dihydro-2′-deoxyguanosine levels were also observed in subjects with lung cancer, but the differences of this biomarker with other diagnoses were not statistically significant (P = .56).
CONCLUSION:
Oxidative damage was observed in all 3 diagnoses, and, as a response to oxidative stress, antioxidant mechanisms were also active in these diseases. Malondialdehyde and 8-oxo-7,8-dihydro-2′-deoxyguanosine were found to be efficiently usable in the evaluation of oxidative damage in chronic respiratory diseases. (ClinicalTrials.gov registration NCT02406053.)
CiencewickiJ, TrivediS, KleebergerSR. Oxidants and the pathogenesis of lung diseases. J Allergy Clin Immunol, 2008; 122(3):456–468.
2.
LoweFJ, LuettichK, GreggEO. Lung cancer biomarkers for the assessment of modified risk tobacco products: an oxidative stress perspective. Biomarkers, 2013; 18(3):183–195.
3.
MacNeeW. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc, 2005; 2(1):50–60.
4.
HatipoğluU, RubinsteinI. Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration, 2003; 70(6):665–671.
5.
SelmiC, MontanoN, FurlanR, KeenCL, GershwinME. Inflammation and oxidative stress in obstructive sleep apnea syndrome. Exp Biol Med (Maywood), 2007; 232(11):1409–1413.
6.
NagaiH, ToyokuniS. Biopersistent fiber-induced inflammation and carcinogenesis: lessons learned from asbestos toward safety of fibrous nanomaterials. Arch Biochem Biophys, 2010; 502(1):1–7.
7.
ChuangHC, FanCW, ChenKY, Chang-ChienGP, ChanCC. Vasoactive alteration and inflammation induced by polycyclic aromatic hydrocarbons and trace metals of vehicle exhaust particles. Toxicol Lett, 2012; 214(2):131–136.
8.
StrakM, JanssenNA, GodriKJ, GosensI, MudwayIS, CasseeFR, et al. Respiratory health effects of airborne particulate matter: the role of particle size, composition, and oxidative potential: the RAPTES project. Environ Health Perspect, 2012; 120(8):1183–1119.
9.
SunilVR, Patel-VayasK, ShenJ, LaskinJD, LaskinDL. Classical and alternative macrophage activation in the lung following ozone-induced oxidative stress. Toxicol Appl Pharmacol, 2012; 263(2):195–202.
10.
JordanW, CohrsS, DegnerD, MeierA, RodenbeckA, MayerG, et al. Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J Neural Transm, 2006; 113(2):239–254.
11.
VassilakopoulosT, KatsaounouP, KaratzaMH, KollintzaA, ZakynthinosS, RoussosC. Strenuous resistive breathing induces plasma cytokines: role of antioxidants and monocytes. Am J Respir Crit Care Med, 2002; 166(12):1572–1578.
12.
DyugovskayaL, LavieP, LavieL. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea subjects. Am J Respir Crit Care Med, 2002; 165(7):934–939.
ChristouK, MarkoulisN, MoulasAN, PastakaC, GourgoulianisKI. Reactive oxygen metabolites (ROMs) as an index of oxidative stress in obstructive sleep apnea subjects. Sleep Breath, 2003; 7(3):105–110.
15.
KontogianniK, Messini-NikolakiN, ChristouK, GourgoulianisK, TsilimigakiS, PiperakisSM. DNA damage and repair capacity in lymphocytes from obstructive sleep apnea subjects. Environ Mol Mutagen, 2007; 48(9):722–727.
16.
PentaJS, JohnsonFM, WachsmanJT, CopelandWC. Mitochondrial DNA in human malignancy. Mutat Res, 2001; 488(2):119–133.
17.
López VarelaMV, Montes de OcaM, HalbertR, MuiñoA, TálamoC, Pérez-PadillaR, et al. Comorbidities and health status in individuals with and without COPD in five Latin American cities: the PLATINO study. Arch Bronconeumol, 2013; 49(11):468–474.
18.
SchroedlC, KalhanR. Incidence, treatment options, and outcomes of lung cancer in subjects with chronic obstructive pulmonary disease. Curr Opin Pulm Med, 2012; 18(2):131–137.
MacNeeW. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc, 2005; 2(4):258–266; discussion 290-291.
21.
ChoWC, KwanCK, YauS, SoPP, PoonPC, AuJS. The role of inflammation in the pathogenesis of lung cancer. Expert Opin Ther Targets, 2011; 15(9):1127–1137.
22.
DorukS, OzyurtH, InonuH, ErkorkmazU, SaylanO, SeyfikliZ. Oxidative status in the lungs associated with tobacco smoke exposure. Clin Chem Lab Med, 2011; 49(12):2007–2012.
23.
RahmanI, BiswasS. Non-invasive biomarkers of oxidative stress: reproducibility and methodological issues. Redox Rep, 2004; 9(3):125–143.
24.
HantaI, KocabasA, CanacankatanN, KuleciS, SeydaogluG. Oxidant-antioxidant balance in subjects with COPD. Lung, 2006; 184(2):51–55.
25.
ChengKC, CahillDS, KasaiH, NishimuraS, LoebLA. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G----T and A----C substitutions. J Biol Chem, 1992; 267(1):166–172.
26.
EvansMD, CookeMS. Factors contributing to the outcome of oxidative damage to nucleic acids. Bioessays, 2004; 26(5):533–542.
27.
TurunenM, OlssonJ, DallnerG. Metabolism and function of coenzyme Q. Biochim Biophys Acta, 2004; 1660(1):171–199.
28.
RabeKF, HurdS, AnzuetoA, BarnesPJ, BuistSA, CalverleyP, et al. “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary,”. Am J Respir Crit Care Med, 2007; 176(6):532–555.
29.
Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep, 1999; 22(5):667–689.
ShigenagaMK, AboujaoudeEN, ChenQ, AmesBN. Assays of oxidative DNA damage biomarkers 8-oxo-2′-deoxyguanosine and 8-oxoguanine in nuclear DNA and biological fluids by high-performance liquid chromatography with electrochemical detection. Methods Enzymol, 1994; 234:16–33.
32.
EdlundPO. Determination of coenzyme Q10, α-tocopherol and cholesterol in biological samples by coupled-column liquid chromatography with coulometric and ultraviolet detection. J Chromatogr, 1988; 425(1):87–97.
33.
MoscaF, FattoriniD, BompadreS, LittarruGP. Assay of coenzyme Q(10) in plasma by a single dilution step. Anal Biochem, 2002; 305(1):49–54.
34.
KhoschsorurGA, Winklhofer-RoobBM, RablH, AuerTh, PengZ, SchaurRJ. Evaluation of a sensitive HPLC method for the determination of malondialdehyde, and application of the method to different biological materials. Chromatographia, 2000; 52(3):181–184.
35.
SchieberM, ChandelNS. ROS function in redox signaling and oxidative stress. Curr Biol, 2014; 24(10):R453–R462.
36.
IshikawaK, TakenagaK, AkimotoM, KoshikawaN, YamaguchiA, ImanishiH, et al. ROS generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science, 2008; 320(5876):661–664.
37.
ChangHW, ChenSY, ChuangLY, GuleriaS. Toxicology and disease/cancer therapy in reactive oxygen species-mediated drugs and treatments. ScientificWorldJournal, 2015; 2015:860563. doi: 10.1155/2015/860563.
38.
AlmendrosI, WangY, BeckerL, LennonFE, ZhengJ, CoatsBR, et al. Intermittent hypoxia-induced changes in tumor-associated macrophages and tumor malignancy in a mouse model of sleep apnea. Am J Respir Crit Care Med, 2014; 189(5):593–601.
FreudenthalerSM, SchreebKH, WieseA, PilzJ, GleiterCH. Influence of controlled hypoxia and radical scavenging agents on erythropoietin and malondialdehyde concentrations in humans. Acta Physiol Scand, 2002; 174(3):231–235.
41.
Abdel-RahmanU, AybekT, MoritzA, KleineP, MatheisG. Graded reoxygenation limits lipid peroxidation during surgical reperfusion. Med Sci Monit, 2003; 9(9):CR389–CR391.
42.
EsmeH, CemekM, SezerM, SaglamH, DemirA, MelekH, UnluM. High levels of oxidative stress in subjects with advanced lung cancer. Respirology, 2008; 13(1):112–116.
43.
LoftS, MøllerP. Oxidative DNA damage and human cancer: need for cohort studies. Antioxid Redox Signal, 2006; 8(5):1021–1031.
44.
HiginbothamKG, RiceJM, DiwanBA, KasprzakKS, ReedCD, PerantoniAO. GGT to GTT transversions in codon 12 of the K-ras oncogene in rat renal sarcomas induced with nickel subsulfide or nickel subsulfide/iron are consistent with oxidative damage to DNA. Cancer Res, 1992; 52(17):4747–4751.
45.
HollsteinM, SidranskyD, VogelsteinB, HarrisCC. p53 mutations in human cancers. Science, 1991; 253(5015):49–53.
46.
LockwoodK, MoesgaardS, YamamotoT, FolkersK. Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases. Biochem Biophys Res Commun, 1995; 212(1):172–177.
47.
BonakdarRA, GuarneriE. Coenzyme Q10. Am Fam Physician, 2005; 72(6):1065–1070.
48.
CobanogluU, DemirH, CebiA, SayirF, AlpHH, AkanZ, et al. Lipid peroxidation, DNA damage and coenzyme Q10 in lung cancer subjects: markers for risk assessment?. Asian Pac J Cancer Prev, 2011; 12(6):1399–1403.
